Press Releases

Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

Read More >

May 6, 2024

Myomo to Report First Quarter Financial Results on May 8, 2024

Read More >

May 1, 2024

Myomo Appoints Heather Getz to its Board of Directors

Read More >

March 28, 2024

Myomo Reports Fourth Quarter and Full Year 2023 Financial Results

Read More >

March 7, 2024

CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®

Read More >

March 1, 2024

Myomo to Report Fourth Quarter Financial Results on March 7, 2024

Read More >

February 29, 2024

Myomo Closes $6M Registered Direct Offering

Read More >

January 19, 2024

Myomo Announces $6M Registered Direct Offering

Read More >

January 17, 2024

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Read More >

January 17, 2024

Myomo Reports Q3 2023 Financial Results

Read More >

November 7, 2023

CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting

Read More >

November 6, 2023

Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category

Read More >

November 2, 2023